Yahoo Web Search

  1. Ads

    related to: multiple sclerosis

Search results

    • Analyst Report: Biogen Inc.

      Morningstar Research via Yahoo Finance· 20 hours ago

      Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation ...

  1. Ads

    related to: multiple sclerosis